Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Novel plug-and-play multi-organ chip can be customized to the patient

Novel plug-and-play multi-organ chip can be customized to the patient

Researchers develop novel device to “cleanse” the blood of chemotherapeutic drugs

Researchers develop novel device to “cleanse” the blood of chemotherapeutic drugs

Vitamin C may help to counteract common side effect of the chemotherapy drug

Vitamin C may help to counteract common side effect of the chemotherapy drug

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Scientists assemble carbon nanotubes in a new way to deliver cancer drugs

Scientists assemble carbon nanotubes in a new way to deliver cancer drugs

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Protein can protect the heart from damage following cancer treatment

Protein can protect the heart from damage following cancer treatment

Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

New system created for targeted delivery of anti-cancer drugs

New system created for targeted delivery of anti-cancer drugs

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Cardiotoxic effects of common chemotherapy drug could be prevented

Cardiotoxic effects of common chemotherapy drug could be prevented

DNMT2/TRDMT1 gene knockout may potentiate adverse effects related to drug-induced senescence

DNMT2/TRDMT1 gene knockout may potentiate adverse effects related to drug-induced senescence

Studies shed light on the versatility, precision, and sensitivity of quantitative analytical tools

Studies shed light on the versatility, precision, and sensitivity of quantitative analytical tools

Anti-cancer prodrug can benefit cancer patients

Anti-cancer prodrug can benefit cancer patients

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit